Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Missouri for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Missouri only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Missouri (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Rohan Jalalizadeh (NPI 1972957538)

Field	Value
Entity Type	Individual
Organization	Rohan Jalalizadeh
Address	3660 Vista Ave
City	Saint Louis
State	MO
ZIP	63110
Taxonomy	Ophthalmology Physician
NPI Enumerated	April 20, 2016

Payer Source	Total Paid
Medicare	$1.7M
Medicaid	$0

Key Findings

This provider bills almost exclusively to Medicare: lifetime Medicare revenue is $1.7M and there is no Medicaid billing on file, so the practice operates effectively as a single-payer (Medicare) outpatient ophthalmology practice in the dataset. The absence of Medicaid volume suggests payor mix and access are strongly weighted toward Medicare beneficiaries rather than state-covered populations.

Revenue is highly concentrated in intravitreal drug administration: the precomputed top-3 Medicare codes (J2777, J0178, J2778) account for 73.2% of this provider's Medicare revenue, reflecting that a majority of dollars flow through anti-VEGF / intraocular biologic injections. This concentration implies the business is structured around recurrent in-office injection encounters rather than primarily surgical or broad multispecialty ophthalmic care.

The code mix and top procedural codes indicate a retina-focused, injection-centered practice model: high revenue shares for J2777 (34.7%), J0178 (29.0%), and J2778 (9.4%) alongside significant use of 67028 (1.4K claims, $141.4K revenue) and advanced imaging 92134 (2.1K claims, $64.3K revenue) point to routine intravitreal therapy with accompanying retinal imaging and office-based injection procedures. These patterns are consistent with management of neovascular AMD, diabetic macular edema, and related retinal conditions.

National competitive standing for the major injectable agents is not extreme: J2777 (34.7% of revenue) ranks #518 of 2039 nationally (75th percentile; typical, unremarkable volume), J0178 (29.0%) ranks #1621 of 3204 (49th percentile; typical, unremarkable volume), and J2778 (9.4%) ranks #466 of 1208 (61th percentile; typical, unremarkable volume). In other words, the provider generates substantial revenue from these drugs locally but does not appear to be an outsized national leader in injection volume for these codes.

Several service lines show above-typical national activity and suggest strong clinic throughput: 92134 ranks #972 of 26868 (96th percentile; notably above typical national volume), 99213 ranks #11125 of 457151 (98th percentile; notably above typical national volume), and 99204 ranks #4804 of 227068 (98th percentile; notably above typical national volume). These elevated percentiles for retinal OCT imaging and common E/M codes imply a high visit and imaging throughput consistent with a busy injection clinic and steady follow-up cadence.

Drug mix shows preferential use of newer agents and limited biosimilar uptake: J2777 (faricimab) is the single largest revenue driver at 34.7% while J0178 (aflibercept) contributes 29.0% and J2778 (ranibizumab) 9.4%. Use of the ranibizumab biosimilar Q5128 is modest (108 claims, $23.2K revenue, 1.4% of total Medicare revenue) and ranks #356 of 373 (5th percentile; typical, unremarkable volume), indicating little reliance on that biosimilar in this billing mix.

Provider tenure is established but not long-standing by some specialty benchmarks: the NPI was enumerated on 2016-04-20 (~10 years ago), consistent with roughly a decade in Medicare billing. That tenure combined with concentrated injection revenue and high imaging/E/M percentiles suggests an established retina-focused practice with a stable referral stream and regular follow-up/injection workflow.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

20 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2777	Injection, faricimab‑svoa, 0.1 mg	20,220	$30	$586.4K
J0178	Injection, aflibercept, 1 mg	710	$690	$489.9K
J2778	Injection, ranibizumab, 0.1 mg	910	$180	$159.6K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,430	$100	$141.4K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,070	$30	$64.3K
J7999	Compounded drug, not otherwise classified	840	$70	$61.5K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	790	$70	$55K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	330	$100	$31.5K
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	110	$220	$23.2K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	200	$120	$23K

Showing 1–10 of 20

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 20 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Missouri Distribution

Rohan Jalalizadeh — 6 of 20 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Missouri

Full comparison — all codes billed, vs. state median

20 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	36	60	820	$690	$683.3K
J2777	8	50	11,730	$30	$388.9K
J2778	6	20	540	$180	$203.8K
Q5128	3	10	940	$220	$153.4K
67028	12	80	600	$90	$69.7K
67042	19	30	20	$1,070	$26.8K
67108	13	20	10	$1,060	$18K
99214	1,486	8,960	100	$80	$13.9K
J7999	1	10	40	$50	$12.7K
99213	135	8,730	70	$50	$7K

Showing 1–10 of 20

Related Providers

Other providers that share a Tax Identification Number (TIN) with Rohan Jalalizadeh, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Sujit Itty	AZ	Ophthalmology Physician	$6.2M	$11.3K
Retinal Consultants Of Arizona Ltd	AZ	Ophthalmology Physician	$0	$6.2M
David Goldenberg	AZ	Retina Specialist (Ophthalmology) Physician	$4.7M	$15.8K
Neal Palejwala	AZ	Ophthalmology Physician	$4.4M	$2.9K
Sachin Mehta	AZ	Retina Specialist (Ophthalmology) Physician	$4.4M	$11.8K
Mahmood El-gasim	AZ	Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician	$3.7M	$0
Karim Jamal	AZ	Ophthalmology Physician	$3.1M	$7.7K
Mark Barakat	AZ	Ophthalmology Physician	$3M	$0
Jordan Graff	AZ	Retina Specialist (Ophthalmology) Physician	$2.8M	$0
Edward Quinlan	AZ	Ophthalmology Physician	$2.6M	$7.1K

Nearby Providers

Other providers in the same ZIP code as Rohan Jalalizadeh, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Council For Extended Care	MO	Intellectual and/or Developmental Disabilities Residential Treatment Facility	$0	$98.1M
St. Louis Children's Hospital	MO	Children's Hospital	$0	$66.9M
Barnes Jewish Hospital	MO	General Acute Care Hospital	$0	$61.4M
Paraquad Inc	MO	Customized Equipment (DME)	$0	$56.3M
Washington University	MO	Multi-Specialty Clinic/Center	$0	$22M
Cooperative Home Care, Inc.	MO	Home Health Agency	$0	$20.6M
Washington University	MO	Multi-Specialty Clinic/Center	$0	$14.8M
New Beginnings In Home Services, LLC	MO	In Home Supportive Care Agency	$0	$11.6M
Washington University	MO	Multi-Specialty Clinic/Center	$0	$10.4M
Washington University	MO	Emergency Care Clinic/Center	$0	$9.1M

Rohan Jalalizadeh — Billing Profile & Reimbursement Data

Sign up for Rohan Jalalizadeh — Billing Profile & Reimbursement Data policy alerts

Rohan Jalalizadeh — Billing Profile & Reimbursement Data

Sign up for Rohan Jalalizadeh — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References